AdvisorShares Psychedelics ETF—— (—)Compass Pathways—— (—)Definium Therapeutics—— (—)GH Research—— (—)Helus Pharma—— (—)MIRA Pharmaceuticals—— (—)Neuphoria Therapeutics—— (—)Eli Lilly—— (—)Johnson & Johnson—— (—)AbbVie—— (—)Otsuka Pharmaceutical—— (—)Numinus Wellness—— (—)Optimi Health—— (—)PharmAla Biotech—— (—)Enveric Biosciences—— (—)Incannex Healthcare—— (—)Aurora Cannabis—— (—)Cronos Group—— (—)SNDL—— (—)Bright Minds Biosciences—— (—)PharmaTher Holdings—— (—)IM Cannabis—— (—)MariMed—— (—)Vireo Growth—— (—)

Loading prices

Bill Tracker · Utah

SB0200

Psilocybin Recommendation Pilot Program Amendments

Status

Did not pass; died when the session ended

2023 Session

IntroducedFeb 10, 2023 (done)
PassedDid not happen (skipped)
SignedDid not happen (skipped)
Law in effectDid not happen (skipped)

Sponsor: Luz Escamilla (Democrat)
Type: Regulation
Substances: Psilocybin

Official text

Summary (from PoliPsy)

Psilocybin Recommendation Pilot Program Amendments

The full bill text and every version are kept by the legislature. We link to it rather than copy it so readers always see the current version.

Read the full bill text

Source: le.utah.gov

Legislative history

March 3, 2023
Failed
March 3, 2023
Failed
March 1, 2023
Committee Report
February 16, 2023
Referred
February 10, 2023
Introduced

Loading bill…